Choline Salicylate

水杨酸胆碱

Report date: 2025/04/24 16:16:26
NME

Base Information

Drug NameCholine Salicylate
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsMultiple MyelomaLymphoma, Mantle-CellLymphoma, Large B-Cell, Diffuse +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaLymphoma, Mantle-CellLymphoma, Large B-Cell, Diffuse +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A